Skip to content

Effectiveness of collaborative care for depressed Chinese people in primary care

Effectiveness of culturally sensitive collaborative treatment of depressed Chinese people in primary care: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN87321950
Enrollment
400
Registered
2008-05-01
Start date
2008-05-01
Completion date
Unknown
Last updated
2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive disorder Mental and Behavioural Disorders Depressive episode

Interventions

The intervention includes consultation to depressed patients by a psychiatrist, treatment of depression by general medical doctors based on established guidelines, and Care Management by a Care Manage

Sponsors

National Health Research Institutes (Taiwan)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who attend non-psychiatric clinics 2. Patients with Major Depressive Disorder (MDD), defined as a positive screen using the Patient Health Questionnaire (PHQ-9), confirmed with the Schedules of Clinical Assessment in Neuropsychiatry (SCAN) interview 3. Men or women aged 18 or older 4. Able to participate in a clinical diagnostic interview in either Mandarin or Fukienese dialects 5. Individuals who are willing to be followed up concerning their depression symptoms 6. Individuals who have completed a written consent form

Exclusion criteria

Exclusion criteria: 1. Women who are pregnant, breast-feeding or planning pregnancy within the next year 2. Patients with serious suicidal risk 3. Patients with unstable medical illnesses 4. Clinical or laboratory evidence of hypothyroidism 5. Patients with comorbid severe mental disorders including: 5.1. Organic mental disorders 5.2. Alcohol or substance abuse disorders active within the last year 5.3. Schizophrenia 5.4. Delusional disorder 5.5. Psychotic disorders not elsewhere classified 5.6. Bipolar disorder 5.7. Mood congruent or mood incongruent psychotic features 6. Patients with history of treatment by a psychiatrist in the past 4 months

Design outcomes

Primary

MeasureTime frame
Rate of adherence to treatment initiation, assessed by blind assessors at baseline and every four weeks from week 2 until week 26 or end point.

Secondary

MeasureTime frame
The following will be assessed by blind assessors at baseline and every four weeks from week 2 until week 26 or end point: 1. Rate of adherence to medication treatment 2. Rate of treatment completers 3. Rate of responders 4. Overall life satisfaction

Countries

Taiwan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026